AIF1 and Gliosis: Since candesartan treatment improved behavior and lowered markers of gliosis, we next evaluated whether Iba1 or GFAP immunostaining correlated with memory-relevant behavior (NOR preference index) in combined data from female E4FAD− and E4FAD+ mice (Supplementary Figure 5A).